|
| HALAZEPAM CIV (200 MG) (AS) Basic information |
Product Name: | HALAZEPAM CIV (200 MG) (AS) | Synonyms: | 1,3-Dihydro-7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one;HALAZEPAM CIV (200 MG) (AS);2,2-trifluoroethyl)-2h-1,4-benzodiazepin-7-chloro-3-dihydro-5-phenyl-1-(2;2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-;2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-;2h-1,4-benzodiazepin-2-one,1,3-dihydro-7-chloro-5-phenyl-1-(2,2,2-trifluoroeth;7-Chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one;7-Chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | CAS: | 23092-17-3 | MF: | C17H12ClF3N2O | MW: | 352.74 | EINECS: | 245-425-4 | Product Categories: | Pharmaceuticals;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Neurochemicals | Mol File: | 23092-17-3.mol | |
| HALAZEPAM CIV (200 MG) (AS) Chemical Properties |
Melting point | 164-166° | Boiling point | 487.8±45.0 °C(Predicted) | density | 1.37±0.1 g/cm3(Predicted) | solubility | DMF: 25 mg/ml; DMSO: 25 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml; Methanol: 1 mg/ml | form | A crystalline solid | pka | 2.61±0.20(Predicted) | EPA Substance Registry System | Halazepam (23092-17-3) |
RIDADR | 3249 | HazardClass | 6.1(b) | PackingGroup | III | Toxicity | LD50 in mice: >4000 mg/kg orally (Steinman) |
| HALAZEPAM CIV (200 MG) (AS) Usage And Synthesis |
Uses | A benzodiazepine derivative that possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a precursor to Desmethyldiazepam (D291595) and is equal to or more effective than Diazepam (D416855) with a lower frequency of side effects.
Controlled Substance. | Definition | ChEBI: Halazepam is an organic molecular entity. | Brand name | Paxipam (Schering). |
| HALAZEPAM CIV (200 MG) (AS) Preparation Products And Raw materials |
|